Please use this identifier to cite or link to this item: http://sgc.anlis.gob.ar/handle/123456789/2042
DC FieldValueLanguage
dc.contributor.authorCorrea, Rita Marieles
dc.contributor.authorFellner, María Doloreses
dc.contributor.authorAlonio, Lidia Virginiaes
dc.contributor.authorDurand, Karinaes
dc.contributor.authorTeyssie, Angelica R.es
dc.contributor.authorPicconi, María Alejandraes
dc.date.accessioned2021-01-05T21:22:00Z-
dc.date.available2021-01-05T21:22:00Z-
dc.date.issued2004-08-
dc.identifier.issn0146-6615-
dc.identifier.urihttp://sgc.anlis.gob.ar/handle/123456789/2042-
dc.descriptionFil: Correa, Rita Mariel. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Virus Oncogénicos; Argentina.es
dc.descriptionFil: Fellner, María Dolores. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Virus Oncogénicos; Argentina.es
dc.descriptionFil: Alonio, Lidia Virginia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Virus Oncogénicos; Argentina.es
dc.descriptionFil: Durand, Karina. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Virus Oncogénicos; Argentina.es
dc.descriptionFil: Teyssié, Angélica R. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Virus Oncogénicos; Argentina.es
dc.descriptionFil: Picconi, María Alejandra. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Virus Oncogénicos; Argentina.es
dc.description.abstractThere are two types of Epstein Barr virus (EBV): EBV-1 and EBV-2, distinguished by genomic polymorphism in the genes encoding the nuclear antigens (EBNA-2, -3A, -3B, -3C). Latent membrane protein 1 (LMP-1) is an EBV protein with known oncogenic properties. Different variants had been described; among them, a 30 base pair (bp) deletion (del-LMP-1) had been reported in benign and malignant pathologies, but there is little information about its frequency in healthy populations. The aim of this study was to determine the distribution of the EBV genotypes and the 30 bp deletion frequency, in EBV healthy carriers from Argentina. Analysis of EBNA-3C and LMP-1 genes were done by polymerase chain reaction (PCR) followed by Southern blot hybridization on DNA of peripheral blood mononuclear cells (PBMCs) from blood bank donors. EBV-1 was present in 75.9% of samples, EBV-2 in 14.6%, and co-infections with both types in 6.5%. The deleted LMP-1 variant was found in 7.4% of analyzed samples, corresponding 3.2% to deleted variant alone and 4.2% to co-infections with non-deleted form. The non-deleted variant was found in 64.6% whereas in the remaining 28%, no PCR product was detected. These results showed that EBV-1 was the more prevalent type in healthy carriers of Argentina, similar to reports from others countries. A predominance of the non-deleted LMP-1 variant was observed. The presence of co-infections with both types and variants demonstrated that healthy individuals may also harbor multiple EBV infections.es
dc.language.isoenes
dc.publisherWileyes
dc.publisherWiley-Liss-
dc.relationdatasets-
dc.relation.ispartofJournal of medical virologyes
dc.rightsOpen Access-
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.sourceJournal of Medical Virology 2004; 73(4):583-588-
dc.subjectAdolescentees
dc.subjectAdultoes
dc.subjectAncianoes
dc.subjectArgentinaes
dc.subjectDonantes de Sangrees
dc.subjectPortador Sanoes
dc.subjectInfecciones por Virus de Epstein-Barres
dc.subjectFemeninoes
dc.subjectVariación Genéticaes
dc.subjectGenotipoes
dc.subjectHerpesvirus Humano 4es
dc.subjectHumanoses
dc.subjectLeucocitos Mononucleareses
dc.subjectMasculinoes
dc.subjectPersona de Mediana Edades
dc.subjectReacción en Cadena de la Polimerasaes
dc.subjectPrevalenciaes
dc.subjectProteínas de la Matriz Virales
dc.subjectEliminación de Secuenciaes
dc.titleEpstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogenees
dc.typeArtículoes
dc.rights.licenseCreative Commons Attribution 4.0 International License-
dc.identifier.doi10.1002/jmv.20129-
anlis.essnrd1-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairetypeArtículo-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
crisitem.author.deptInstituto Nacional de Enfermedades Infecciosas (INEI)-
crisitem.author.deptDepartamento de Virología-
crisitem.author.deptServicio Virus Oncogénicos-
crisitem.author.deptAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
crisitem.author.deptInstituto Nacional de Enfermedades Infecciosas (INEI)-
crisitem.author.deptDepartamento de Virología-
crisitem.author.deptServicio Virus Oncogénicos-
crisitem.author.parentorgAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
crisitem.author.parentorgInstituto Nacional de Enfermedades Infecciosas (INEI)-
crisitem.author.parentorgDepartamento de Virología-
crisitem.author.parentorgAdministración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS)-
crisitem.author.parentorgInstituto Nacional de Enfermedades Infecciosas (INEI)-
crisitem.author.parentorgDepartamento de Virología-
Appears in Collections:Publicaciones INEI
Show simple item record

Page view(s)

23
checked on May 2, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons